Bray June has filed 7 insider transactions across 2 companies since June 2023.
Most recent transaction: a grant/award of 18724 shares of Quince Therapeutics, Inc. ($QNCX) on January 02, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 2, 2026 | Quince Therapeutics, Inc. | $QNCX | Bray June | Not found | A | Director Stock Option (Right to Buy) | 18724 | $0.00 | 18,724.0000 | 55,681,490 | 9999.99% | 0.03% |
| Jan. 9, 2026 | BioXcel Therapeutics, Inc. | $BTAI | Bray June | Director | A | Stock Option (Right to Buy) | 17000 | $0.00 | 17,000.0000 | 14,196,000 | 9999.99% | 0.12% |
| June 4, 2025 | Quince Therapeutics, Inc. | $QNCX | Bray June | Not found | A | Director Stock Option (Right to Buy) | 27000 | $0.00 | 27,000.0000 | 44,001,643 | 9999.99% | 0.06% |
| Jan. 2, 2025 | Quince Therapeutics, Inc. | $QNCX | Bray June | Not found | A | Director Stock Option (right to buy) | 30282 | $0.00 | 30,282.0000 | 0 | 9999.99% | 0.00% |
| June 10, 2024 | BioXcel Therapeutics, Inc. | $BTAI | Bray June | Director | A | Stock Option (Right to Buy) | 17000 | $0.00 | 17,000.0000 | 1,929,000 | 9999.99% | 0.88% |
| June 5, 2024 | Quince Therapeutics, Inc. | $QNCX | Bray June | Not found | A | Employee Stock Option (right to buy) | 27000 | $0.00 | 27,000.0000 | 0 | 9999.99% | 0.00% |
| June 26, 2023 | BioXcel Therapeutics, Inc. | $BTAI | Bray June | Director | A | Stock Option (Right to Buy) | 17000 | $0.00 | 17,000.0000 | 28,616,000 | 9999.99% | 0.06% |